Effect of Fasting on the Asthma Inflammasome
NCT02471300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19
Last updated 2021-02-01
Summary
Background:
Research shows that restricting calories has a positive effect on immune cell health in healthy people. Researchers want to learn if it will help people with asthma. They want to better understand how the body s immune response and lung function responds to short-term calorie restriction. For this, they want people to fast (no food or drink except water) for 24 hours.
Objective:
To explore the benefits of calorie restriction in people with asthma.
Eligibility:
Healthy people ages 18 to 60 who have a history consistent with asthma and prior documentation of airflow obstruction or wheezing.
Design:
* Participants who have taken part in asthma research at NIH will be screened with a telephone interview. All other participants will have a medical history, blood tests, and physical exam.
* Eligible participants will return to the NIH Clinical Center one morning for 2 hours. They will be fed breakfast. They may have blood and urine tests.
* Participants will then fast for 24 hours.
* Participants will return to the Clinical Center the next morning for 4 hours. They will have blood drawn. They will eat breakfast and then repeat blood draws 2.5 hours later. They will have a urine test.
* Blood and urine tests will be done at the end of the fast and after the meals to confirm that the participant fasted for the full 24-hour period.
* Participants will have lung function tests and exhaled gas measurements. A machine will measure the volume of air they can breathe out. Some gases in the breath increase with inflammation. Participants will breathe into a machine that analyzes the gases in their breath.
Conditions
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Michael N Sack, M.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-26
- Primary Completion
- 2017-03-06
- Completion
- 2021-01-27
Countries
- United States
Study Locations
More Related Trials
-
Inflammatory Markers in Exhaled Breath Condensates From Asthmatic Patients
NCT01246414 ·Status: COMPLETED
-
BREATHE-Easy Trial
NCT03200522 ·Status: TERMINATED ·Phase: NA
-
Pilot of Lifestyle and Asthma Intervention
NCT03291808 ·Status: COMPLETED ·Phase: NA
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Statin Treatment in Patients With Asthma
NCT00292201 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
NCT00559689 ·Status: COMPLETED
-
Flexibility and Strength Training in Asthma
NCT02370004 ·Status: COMPLETED ·Phase: NA
-
Nutrition for Asthmatics
NCT06151405 ·Status: RECRUITING ·Phase: NA
-
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
NCT05035862 ·Status: TERMINATED ·Phase: PHASE1
-
Role of T-Cells in Asthma
NCT00001408 ·Status: COMPLETED
-
Intervention to Improve Asthma Management/Prevention
NCT00005734 ·Status: COMPLETED
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Magnesium and Asthma - Clinical Trials
NCT00029510 ·Status: COMPLETED ·Phase: PHASE2
-
Soluble CD23 Expression in Asthma Patients Treated With OMA
NCT00226200 ·Status: TERMINATED ·Phase: NA
-
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
NCT00001909 ·Status: COMPLETED ·Phase: PHASE2
-
Peer Led Asthma Self Management for Adolescents: PLASMA
NCT02293499 ·Status: COMPLETED ·Phase: PHASE2
-
Coupled Inspiratory and Expiratory Muscle Training in Children With Bronchial Asthma
NCT05212558 ·Status: COMPLETED ·Phase: NA
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Inhaled Corticosteroids on Airway Smooth Muscle in Asthma
NCT00661973 ·Status: WITHDRAWN ·Phase: PHASE4
-
Steroid Titration Against Mannitol IN Asthma
NCT01216579 ·Status: COMPLETED ·Phase: NA
-
Asthma Inflammation Research
NCT01536522 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1